Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio

DUBLIN and SOUTH SAN FRANCISCO, Calif.: DUBLIN and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced strategic actions to focus on leveraging its expertise in developing and commercializing respiratory therapeutics in order to maximize shareholder value. These...

Click to view original post